Evidence map›Paper›PMID 28607084›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Systems-guided forward genetic screen reveals a critical role of the replication stress response protein ETAA1 in T cell clonal expansion.

Lisa A Miosge, Yovina Sontani, Aaron Chuah, Keisuke Horikawa, Tiffany A Russell, Yan Mei, Mayura V Wagle, Debbie R Howard, Anselm Enders, David C Tscharke and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. NMolecular neurobiology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. DNA damage responses that enhance resilience to replication stress.Cellular and molecular life sciences : CMLS · 2021
    Review
  8. Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM).Critical reviews in biochemistry and molecular biology · 2021
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Targeting ATR in cancer.Nature reviews. Cancer · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Lisa A MiosgeJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Yovina SontaniJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Aaron ChuahJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Keisuke HorikawaJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Tiffany A RussellJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Yan MeiJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Mayura V WagleJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Debbie R HowardJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Anselm EndersJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
David C TscharkeJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
Christopher C GoodnowJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia; c.goodnow@garvan.org.au ian.parish@anu.edu.au.
Ian A ParishJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia; c.goodnow@garvan.org.au ian.parish@anu.edu.au.
Australian National University · AUGarvan Institute of Medical Research · AU

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
NIAID NIH HHS U19 AI100627
6 · The paper itself

Abstract

T-cell immunity requires extremely rapid clonal proliferation of rare, antigen-specific T lymphocytes to form effector cells. Here we identify a critical role for ETAA1 in this process by surveying random germ line mutations in mice using exome sequencing and bioinformatic annotation to prioritize mutations in genes of unknown function with potential effects on the immune system, followed by breeding to homozygosity and testing for immune system phenotypes. Effector CD8

Indexed as

Immunity, CellularMutationAnimalsAntigens, SurfaceAtaxia Telangiectasia Mutated ProteinsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DivisionHerpes SimplexHerpesvirus 1, HumanLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, Mutant StrainsTumor Suppressor Protein p53Antigens, SurfaceAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseAtr protein, mouseETAA1 protein, humanTumor Suppressor Protein p53DNA damageEtaa1immunityreplication stressT cell

Identifiers

PMID28607084
PMCPMC5495275
OpenAlexW2625208233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.